Conclusions
Obviously, the introduction of new antihypertensive drugs, as promising they may ever be, will by itself not lead to an improvement of the overall quality of hypertension care in diabetic patients. Rather, the standards of hypertension care in unselected patient populations will depend (on the part of physicians) on systematic attempts to diagnose early and to initiate effective therapy, and (on the part of patients) on adherance to agreed therapeutic procedures [26].
In contrast to the tremendous interest in new pharmaceutical principles in antihypertensive therapy, surprisingly few attempts have been directed towards assessment and improvement of overall quality of hypertension care in diabetic patients. The few available data indicate very infrequent blood pressure measurements in diabetic patients both in general practitioners' offices and in diabetes centres [45, 46], and high percentages of patients with either untreated hypertension [47] or insufficient blood pressure control despite treatment [26, 46].
These problems are most unlikely to be solved by the mere introduction of ACEIs or any other new antihypertensive drug. One may even fear that the emphasis on promoting such new, still incompletely evaluated drugs may detract physicians and patients from the necessity to comply to tedious rules of long-term hypertension care using well established therapeutic principles. On the other hand, one might hope that the present most active marketing campaign for ACEIs will foster the interest for the real problems of hypertension care in diabetes. In this indirect way, the ACEIs may indeed contribute to the urgently needed improvement of hypertension care in diabetic patients.
Article PDF
Similar content being viewed by others
References
Mogensen CE (1982) Long term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285: 685–688
Parving HH, Hommel E (1989) Prognosis in diabetic nephropathy. Br Med J 299: 230–233
Panzram G (1987) Mortality and survival in Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 123–131
The Working Group on Hypertension in Diabetes (1987) Statement on hypertension in diabetes. Final Report. Arch Intern Med 147: 830–842
Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM (1986) Prevention of diabetic glomerulopathy by pharmacological ameloration of glomerular capillary hypertension. J Clin Invest 77: 1925–1930
Bank N, Klose R, Aynedjian HS, Nguyen D, Sablay LB (1987) Evidence against increased glomerular pressure initiating diabetic nephropathy. Kidney Int 31: 898–905
Yoshioka T, Shiraga H, Yoshida Y, Fogo A, Glick AD, Deen WM, Hoyer JR, Ichikawa I (1988) “Intact Nephrons” as the primary origin of proteinuria in chronic renal disease. J Clin Invest 82: 1614–1623
Baba T, Sawicki PT (1989) Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat: are these effects specific for enalapril? Diabetologia 32: 829 (letter)
Drummond K, Levy-Marchal C, Laborde K, Kindermans C, Wright C, Dechaux M, Czernichow P (1989) Enalapril does not alter renal function in normotensive, normoalbuminuric, hyper-filtering Type 1 (insulin-dependent) diabetic children. Diabetologia 32: 255–260
Baba T, Murabayashi S, Takabe K (1989) Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive Type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial. Diabetologia 32: 40–44
Taguma Y, Kitamoto Y, Futaki G, Ueda H, Monma H, Ishizaki M, Takahashi H, Sekino H, Sasaki Y (1985) Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 313: 1617–1620
Hay U, Ludvik B, Gisinger Ch, Schernthaner G (1988) Fehlender Effekt der ACE-Inhibition auf die Makroproteinurie bei diabetischer Nephropathie — eine Langzeitstudie über 6 Monate. Schw Med Wochenschr 118: 165–169
Parving HH, Hommel E, Smidt UM (1988) Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. Br Med J 297: 1086–1091
Marre M, Leblanc H, Suarez L, Guyenne TT, Menard J, Passa P (1987) Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J 294: 1448–1452
Parving HH, Hommel E, Nielsen MD, Giese J (1988) Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. Br Med J 299: 533–536
World Health Organisation (1986) Guidelines for treatment of mild hypertension: memorandum from a WHO/ISH meeting. Bulletin of WHO 64: 31–35
Friedmann PJ, Dunn PJ, Jury DR (1986) Metoprolol and albumin excretion in diabetes. Lancet II: 1042–1043 (letter)
Rett K, Wicklmayr M, Tschollar G, Dietze G, Mehnert H (1988) Role of angiotensin-converting enzyme inhibitors in early antihypertensive treatment in non-insulin dependent diabetes mellitus. Postgrad Med J 64 [Suppl 3]: 69–73
Pollare T, Lithell H, Selinus I, Berne C (1988) Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia 31: 415–420
Moore MP, Elliott TW, Nicholls MG (1988) Hormonal and metabolic effects of enalapril treatment in hypertensive subjects with NIDDM. Diabetes Care 11: 397–401
Croog SH, Levine S, Terta MA, et al. (1986) The effects of antihypertensive therapy on the quality of life. N Engl J Med 34: 1657–1664
Edmonds D, Greminger P, Locher R, Knorr M, Vetter H, Vetter W (1986) Enalapril as a first-step agent in essential hypertension: a comparative study with atenolol. J Hypertension 4 [Suppl 5]: 406–409
Woo J, Woo KS, Kin T, Vallance-Owen J (1987) A single-blind, randomized, cross-over study of angiotensin-converting enzyme inhibitor and triamterene and hydrochlorothiazide in the treatment of mild to moderate hypertension in the elderly. Arch Intern Med 147: 1386–1389
Clausen-Sjöborm N, Lins PE, Adamson U, Curstedt T, Hamberger B (1987) Effects of metoprolol on the counter-regulation and recognition of prolonged hypoglycemia in insulin-dependent diabetics. Acta Med Scand 222: 57–63
Blohme G, Lager I, Lönnroth P, Smith U (1981) Hypoglycaemic symptoms in insulin-dependent diabetics. A prospective study on the influence of beta-blockade. Diabete and Metab 7: 235–238
Mühlhauser I, Sawicki P, Didjurgeit U, Jörgens V, Berger M (1988) Uncontrolled hypertension in IDDM Assessment of patients' desires about hypertension treatment and improvement of blood pressure control by a structured hypertension treatment and teaching programme. Diab Med 5: 693–698
Rett K, Wicklmayr M, Dietze GJ (1988) Hypoglycaemia in hypertensive diabetic patients treated with sulfonylureas, biguanides and captopril. N Engl J Med 24: 1609 (letter)
Amery A, Berthaux P, Bulpitt C, Deruyttere M, Schaepdryver A, Dollery C, Fagard R, Forette F, Hellemans J, Lund-Johansen P, Mutsers A, Tuomilehto J (1978) Glucose interolance during diuretic therapy. Results of trial by the European working party on hypertension in the elderly. Lancet I: 681–683
Pollare T, Lithell H, Berne C (1989) A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 321: 868–873
Vardan S, Mehrotra KG, Mookherjee S, Willsey GA, Gens JD, Green DE (1987) Efficacy and reduced metabolic side effects of 15 mg chlorthalidone formulation in the treatment of mild hypertension. JAMA 258: 484–488
Wright AD, Barber SG, Kendall MJ, Poole PH (1979) Betaadrenoceptor-blocking drugs and blood sugar control in diabetes mellitus. Br Med J I: 159–161
Pollare T, Lithell H, Selinus I, Berne C (1989) Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. Br Med J 298: 1152–1157
Skarfors ET, Lithell HO, Selinus I, Aberg H (1989) Do antihypertensive drugs precipitate diabetes in predisposed men? Br Med J 298: 1147–1152
Bains W (1989) Antihypertensive drugs and diabetes in predisposed men. Br Med J 298: 1643 (letter)
Burris JF, Freis ED (1985) Thiazids do not cause long-term increases in serum lipid concentrations. Arch Intern Med 145: 2264–2265
Moser M (1988) In defense of traditional antihypertensive therapy. Hypertension 12: 324–326
Wilkstrand J, Warnold I, Olsson G, Tuomilehto J, Elmfeldt D, Berglund G (1988) Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY Study. JAMA 259: 1976–1982
Mehta N, Modi N, Broughton Pipkin F, Baker PN, Symonds EM (1989) ACE inhibitors in pregnancy. Lancet II: 96–97 (letter)
Weidmann P, Beretta-Piccoli C, Keusch G, Glück Z, Mujagic M, Grimm M, Meier A, Ziegler WH (1979) Sodium-volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus. Am J Med 67: 779–784
Ray WA, Griffin MR, Downey W, Melton III LS (1989) Longterm use of thiazide diuretics and risk of hip fracture. Lancet I: 687–690
Valvo E, Bedogna V, Casagrande P, Antiga L, Zamboni M, Bommartini F, Oldrizzi L, Rugiu C, Maschio G (1988) Captopril in patients with type 2 diabetes and renal insufficiency: systemic and renal hemodynamic alterations. Am J Med 85: 344–348
Packer M, Lee WH, Medina N, Yushak M, Kessler PD, Gottlieb SS (1987) Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure. Am J Med 82: 1119–1126
Webster J, Murchison LE, Robb OJ (1988) Angiotensin converting enzyme inhibitors may cause renal impairment in diabetes mellitus. Scott Med 33: 247–248
Sawicki PT, Kaiser S, Ehle B, Frenzel H, Kemmer F (1989) Autopsy study on renal artery stenosis in diabetes mellitus. Diabetes 38 [Suppl 2]: 129A
Day JL, Humphreys H, Alban-Davies H (1987) Problems of comprehensive shared diabetes care. Br Med J 294: 1590–1592
Billault B, Leblanc H, Passa Ph (1988) Care of arterial hypertension in 612 insulin-treated diabetic outpatients. Second International Symposium on Hypertension Associated with Diabetes Mellitus. Paris. Abstract Volume, pp 0–3
Parving HH, Hommel E, Mathiesen E, Skott P, Edsberg B, Bahnsen M, Lauritzen M, Hougaard P, Lauritzen E (1989) Prevalence of microalbuminuria, hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J 296: 156–160
Author information
Authors and Affiliations
Additional information
The section “For debate...” is open to contributions dealing with issues of a particularly debatable nature in diabetology. Contributions are published either standing by themselves or accompanied by invited comments. Other comments from the readership may be published as Letters to the Editor. Manuscripts intended for publication in this section of the journal are accepted at the discretion of the Editor-in-Chief and may be subject to a referee procedure.
Rights and permissions
About this article
Cite this article
Sawicki, P.T., Mühlhauser, I., Baba, T. et al. Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus?. Diabetologia 33, 121–124 (1990). https://doi.org/10.1007/BF00401052
Issue Date:
DOI: https://doi.org/10.1007/BF00401052